Ocumension Therapeutics is a Chinese ophthalmology pharmaceutical platform company focused on building an ophthalmology medicine platform that integrates the full-cycle professional capabilities of eye medicine development from research and development, manufacturing to commercialization. The company was founded in 2018, and headquartered in Shanghai City, China.
Headquarters
502-1 Want Want Plaza, 211 Shimen Yi Road, Jing'An District, Prc
Shanghai; Shanghai;
Contact Details: Purchase the Ocumension Therapeutics (Hong Kong) report to view the information.
Website: http://www.ocumension.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service